US officials insist PrEP research 'imperative,' despite halted Truvada study in women
22 April 2011
Donna Young
Please Login to read the full article.
22 April 2011
Donna Young
donna.young@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: US health officials reflect on 30 years of HIV/AIDS
- US Capitol Capsule: Will sequestration be a better outcome for biopharma?
- After marathon session, US FDA panel backs Gilead’s Truvada in HIV PrEP
- Adherence, REMS expected AdCom focus for Gilead's Truvada in HIV PrEP
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
